- Home
- NBTX vs FRST Comparison
NBTX vs FRST Comparison
Compare NBTX & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- FRST
- Stock Information
- Founded
- NBTX 2003
- FRST 2004
- Country
- NBTX France
- FRST United States
- Employees
- NBTX N/A
- FRST N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- FRST Major Banks
- Sector
- NBTX Health Care
- FRST Finance
- Exchange
- NBTX Nasdaq
- FRST Nasdaq
- Market Cap
- NBTX 211.9M
- FRST 220.5M
- IPO Year
- NBTX 2020
- FRST 2006
- Fundamental
- Price
- NBTX $4.57
- FRST $11.03
- Analyst Decision
- NBTX Strong Buy
- FRST Buy
- Analyst Count
- NBTX 1
- FRST 1
- Target Price
- NBTX $8.00
- FRST $420.00
- AVG Volume (30 Days)
- NBTX 7.1K
- FRST 80.9K
- Earning Date
- NBTX 04-02-2025
- FRST 07-24-2025
- Dividend Yield
- NBTX N/A
- FRST 3.69%
- EPS Growth
- NBTX N/A
- FRST N/A
- EPS
- NBTX N/A
- FRST 0.16
- Revenue
- NBTX N/A
- FRST $125,133,000.00
- Revenue This Year
- NBTX N/A
- FRST $21.33
- Revenue Next Year
- NBTX $221.06
- FRST $12.77
- P/E Ratio
- NBTX N/A
- FRST $67.58
- Revenue Growth
- NBTX N/A
- FRST 22.34
- 52 Week Low
- NBTX $2.76
- FRST $7.59
- 52 Week High
- NBTX $6.00
- FRST $13.52
- Technical
- Relative Strength Index (RSI)
- NBTX 52.43
- FRST 74.89
- Support Level
- NBTX $4.31
- FRST $10.40
- Resistance Level
- NBTX $5.00
- FRST $11.16
- Average True Range (ATR)
- NBTX 0.25
- FRST 0.23
- MACD
- NBTX -0.06
- FRST 0.09
- Stochastic Oscillator
- NBTX 24.44
- FRST 91.33
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit.